Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

RTL therapy for multiple sclerosis: a Phase I clinical study.
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Nephrotic Syndrome in a Multiple Sclerosis Patient Receiving Long-term Interferon Beta Therapy.
Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses.
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
Pharmacodynamics of Dimethyl Fumarate are Tissue-specific and Involve NRF2-dependent and -independent Mechanisms.
Opinion: Sex inclusion in basic research drives discovery.
Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
FDA approval announcement for ofatumumab
Complex antibody profiling to predict clinical outcome in childhood ADS.
LC-MS/MS determination of FTY720 and FTY720-phosphate in murine intracellular compartments and human plasma.
Receptos to initiate Phase 3 trial of RPC1063 in relapsing multiple sclerosis
A G protein-coupled receptor is essential for Schwann cells to initiate myelination.
No Differences Observed among Multiple Clinical S1P1 Receptor Agonists (Functional Antagonists) in S1P1 Receptor Down-regulation and Degradation.
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
NICE recommends new treatment option for multiple sclerosis (Dimethyl fumarate)
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Benign multiple sclerosis: a distinct clinical entity with therapeutic implications.
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA).
Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Gait Mechanics are Different between Healthy Controls and Patients with Multiple Sclerosis.

Pages